Penumbra (PEN) Income from Continuing Operations (2014 - 2026)
Penumbra (PEN) reported Income from Continuing Operations of 32588000.0 for Q1 2026, down 16.99% year-over-year from 39258000.0 in Q1 2025, and down 31.09% on a QoQ basis from 47294000.0 in Q4 2025.
Penumbra (PEN) has 13 years of Income from Continuing Operations data on file, last reported at 32588000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 16.99% year-over-year to 32588000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 170977000.0 (up 304.73% YoY) and the FY2025 annual result came in at 177687000.0, up 1168.11% from the prior year.
- Income from Continuing Operations fell to 32588000.0 in Q1 2026 per PEN's latest filing, from 47294000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 54218000.0 in Q4 2023 and bottomed at 60174000.0 in Q2 2024.
- The 5-year median for Income from Continuing Operations is 18960000.0 (2023), against an average of 18422352.94.
- The widest annual swing landed in 2023, when Income from Continuing Operations surged 10725.32%; it then slumped 417.37% in 2024.
- Tracing PEN's Income from Continuing Operations over 5 years: stood at 3877000.0 in 2022, then soared by 1298.45% to 54218000.0 in 2023, then sank by 37.87% to 33683000.0 in 2024, then jumped by 40.41% to 47294000.0 in 2025, then plunged by 31.09% to 32588000.0 in 2026.
- Per Business Quant, the three latest PEN Income from Continuing Operations figures stand at 32588000.0 (Q1 2026), 47294000.0 (Q4 2025), and 45825000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 32.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.59 Mn |
| Dec 31, 2025 | 47.29 Mn |
| Sep 30, 2025 | 45.83 Mn |
| Jun 30, 2025 | 45.27 Mn |
| Mar 31, 2025 | 39.26 Mn |
| Dec 31, 2024 | 33.68 Mn |
| Sep 30, 2024 | 29.48 Mn |
| Jun 30, 2024 | -60.17 Mn |
| Mar 31, 2024 | 11.03 Mn |
| Dec 31, 2023 | 54.22 Mn |
| Sep 30, 2023 | 9.20 Mn |
| Jun 30, 2023 | 18.96 Mn |
| Mar 31, 2023 | 8.55 Mn |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2022 | -2.27 Mn |
| Jun 30, 2022 | -3.69 Mn |
| Mar 31, 2022 | 79,000.00 |
| Dec 31, 2021 | -24.63 Mn |
| Sep 30, 2021 | 8.03 Mn |
| Jun 30, 2021 | 8.30 Mn |
| Mar 31, 2021 | 10.93 Mn |
| Dec 31, 2020 | 2.63 Mn |
| Sep 30, 2020 | -9.88 Mn |
| Jun 30, 2020 | -12.90 Mn |
| Mar 31, 2020 | 888,000.00 |
| Dec 31, 2019 | 9.30 Mn |
| Sep 30, 2019 | 11.00 Mn |
| Jun 30, 2019 | 16.25 Mn |
| Mar 31, 2019 | 10.45 Mn |
| Dec 31, 2018 | 6.46 Mn |
| Sep 30, 2018 | -21.51 Mn |
| Jun 30, 2018 | 14.61 Mn |
| Mar 31, 2018 | 6.44 Mn |
| Dec 31, 2017 | 9.81 Mn |
| Sep 30, 2017 | 783,000.00 |
| Jun 30, 2017 | -1.40 Mn |
| Mar 31, 2017 | -3.11 Mn |
| Dec 31, 2016 | -2.40 Mn |
| Sep 30, 2016 | 11.91 Mn |
| Jun 30, 2016 | 3.01 Mn |
| Mar 31, 2016 | 2.29 Mn |
| Dec 31, 2015 | 1.63 Mn |
| Sep 30, 2015 | 901,000.00 |
| Jun 30, 2015 | -2.67 Mn |
| Mar 31, 2015 | 2.50 Mn |
| Dec 31, 2014 | 416,000.00 |
| Sep 30, 2014 | 172,000.00 |
| Jun 30, 2014 | 526,000.00 |
| Mar 31, 2014 | 1.80 Mn |